$-0.05
(Market cap
$131 Mln
Revenue (TTM)
$58 Mln
P/E Ratio
--
P/B Ratio
12
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.9 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-5.3
-
Debt to Equity
3.3
-
Book Value
$--
-
EPS
$-0.2
-
Face value
--
-
Shares outstanding
42,124,023
10 Years Aggregate
CFO
$-104.27 Mln
EBITDA
$-127.24 Mln
Net Profit
$-56.40 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Apyx Medical Inc (APYX)
| -14.3 | -23.5 | -26.7 | 44.2 | -11.3 | -23.1 | -3.5 |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Apyx Medical Inc (APYX)
| 121.5 | -39.4 | 12.0 | -81.7 | 78.1 | -14.9 | 30.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Apyx Medical Inc (APYX)
|
3.0 | 131.4 | 58.4 | -8.6 | -4.1 | -70.3 | -- | 12.0 |
| 64.9 | 8,484.6 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.1 | |
| 14.6 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 59.3 | 9,074.5 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 181.9 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.5 | 6,525.3 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24 | 5.0 | |
| 89.5 | 5,420.5 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 321.0 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 182.0 | 10,222.2 | 785.1 | 41.5 | 9.9 | 2 | 251.6 | 4.8 |
Shareholding Pattern
View DetailsAbout Apyx Medical Inc (APYX)
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics... and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida. Read more
-
President, CEO & Director
Mr. Charles D. Goodwin II
-
President, CEO & Director
Mr. Charles D. Goodwin II
-
Headquarters
Clearwater, FL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Apyx Medical Inc (APYX)
What is the current share price of Apyx Medical Inc (APYX) Today?
The share price of Apyx Medical Inc (APYX) is $3.00 (NASDAQ) as of 27-Aug-2026 16:00 EDT. Apyx Medical Inc (APYX) has given a return of -11.31% in the last 3 years.
What is the current PB & PE ratio of Apyx Medical Inc (APYX)?
Since, TTM earnings of Apyx Medical Inc (APYX) is negative, P/E ratio is not available.
The P/B ratio of Apyx Medical Inc (APYX) is 11.97 times as on 21-Aug-2026, a 212 premium to its peers’ median range of 3.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-13.16 |
10.15 |
2024 |
-2.57 |
4.25 |
2023 |
-4.85 |
3.40 |
2022 |
-3.49 |
2.15 |
2021 |
-29.04 |
8.21 |
What is the 52 Week High and Low of Apyx Medical Inc (APYX)?
The 52-week high and low of Apyx Medical Inc (APYX) are Rs 5.08 and Rs 1.70 as of 28-Aug-2026.
What is the market cap of Apyx Medical Inc (APYX)?
Apyx Medical Inc (APYX) has a market capitalisation of $ 131 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Apyx Medical Inc (APYX)?
Before investing in Apyx Medical Inc (APYX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.